Therefore, it appears that the alterations caused by RBP disfunction in MS could result either from their incorrect nucleocytoplasmic localization, as in the case of TDP-43 and HnRNPA1, or from a change in their expression levels, as in the case of HuR. Here, HNRNPA1 is linked to myeloid sarcoma.